Search Results - "Schol, J."

Review article: Functional dyspepsia—a gastric disorder, a duodenal disorder or a combination of both? by Broeders, B. W. L. C. M., Carbone, F., Balsiger, L. M., Schol, J., Raymenants, K., Huang, I., Verheyden, A., Vanuytsel, T., Tack, J.

“…Summary Background Functional dyspepsia (FD) is one of the most frequent conditions in gastroenterological outpatient health care. Most recent research in FD…”
Get full text

Current and emerging therapeutic options for the management of functional dyspepsia by Vandenberghe, A, Schol, J, Van den Houte, K, Masuy, I, Carbone, F, Tack, J

“…: Functional Dyspepsia (FD), defined as chronic symptoms originating from the gastroduodenal region in absence of readily identifiable organic disease, is one…”
Get more information

Single-cell transcriptomics in bone marrow delineates CD56dimGranzymeK+ subset as intermediate stage in NK cell differentiation by Melsen, Janine E., van Ostaijen-ten Dam, Monique M., Schoorl, Dorenda J. A., Schol, Pieter J., van den Homberg, Daphne A. L., Lankester, Arjan C., Lugthart, Gertjan, Schilham, Marco W.

“…Human natural killer (NK) cells in lymphoid tissues can be categorized into three subsets: CD56 bright CD16 + , CD56 dim CD16 + and CD69 + CXCR6 + lymphoid…”
Get full text

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis by Schol, J., Wauters, L., Dickman, R., Drug, V., Mulak, A., Serra, J., Enck, P., Tack, J., Accarino, Anna, Barbara, Giovanni, Bor, Serhat, Coffin, Benoit, Corsetti, Maura, De Schepper, Heiko, Dumitrascu, Dan, Farmer, Adam, Gourcerol, Guillaume, Hauser, Goran, Hausken, Trygve, Karamanolis, George, Keszthelyi, Daniel, Malagelada, Carolina, Milosavljevic, Tomislav, O'Morain, Colm, Papathanasopoulos, Athanassos, Pohl, Daniel, Rumyantseva, Diana, Sarnelli, Giovanni, Savarino, Edoardo, Sheptulin, Arkady, Smet, Annemieke, Stengel, Andreas, Storonova, Olga, Storr, Martin, Törnblom, Hans, Vanuytsel, Tim, Velosa, Monica, Waluga, Marek, Zarate, Natalia, Zerbib, Frank

Get full text

EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade by Tabasum, Saba, Thapa, Dinesh, Giobbie-Hurder, Anita, Weirather, Jason L, Campisi, Marco, Schol, Pieter J, Li, Xiaoyu, Li, Jingjing, Yoon, Charles H, Manos, Michael P, Barbie, David A, Hodi, F Stephen

“…Immune checkpoint blockade (ICB) has become the standard of care for several solid tumors. Multiple combinatorial approaches have been studied to improve…”
Get more information

Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n‐acetylgalactosamine (GalNAc) peptides by von Mensdorff‐Pouilly, Silvia, Petrakou, Eftichia, Kenemans, Peter, van Uffelen, Kees, Verstraeten, Albert A., Snijdewint, Frank G.M., van Kamp, Gerard J., Schol, Dick J., Reis, Celso A., Price, Michael R., Livingston, Philip O., Hilgers, Joseph

“…Antibodies (Abs) to MUC1 occur naturally in both healthy subjects and cancer patients and can be induced by MUC1 peptide vaccination. We compared the…”
Get full text

Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast by Mommers, Ellen C.M., Leonhart, Angelique M., von Mensdorff‐Pouilly, Silvia, Schol, Dick J., Hilgers, Jo, Meijer, Chris J.L.M., Baak, Jan P.A., van Diest, Paul J.

“…MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human…”
Get full text

Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1 by Ryuko, K, Schol, D J, Snijdewint, F G, von Mensdorff-Pouilly, S, Poort-Keesom, R J, Karuntu-Wanamarta, Y A, Verstraeten, R A, Miyazaki, K, Kenemans, P, Hilgers, J

“…A monoclonal antibody (MAb), VU-2-G7, was generated against a synthetic 60-mer MUC1 triple tandem repeat peptide with N-acetyl-galactosamine (GalNAc) O-linked…”
Get more information

Repeatability of the timing of eye–hand coordinated movements across different cognitive tasks by de Boer, C., van der Steen, J., Schol, R.J., Pel, J.J.M.

“…•We studied the validity and repeatability of the timing of eye–hand movements.•We used a short testing procedure consisting of eight trial repetitions.•Timing…”
Get full text

Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212 by KITTY MOOLENAAR, C. E. C, MULLER, E. J, SCHOL, D. J, FIGDOR, C. G, BOCK, E, BITTER-SUERMANN, D, MICHALIDES, R. J. A. M

“…Monoclonal antibodies (MAbs) 123C3 and 123A8 generated against a membrane preparation of a small cell lung carcinoma (SCLC) specimen recognize not only SCLC…”
Get full text

Characterization and properties of nine human ovarian adenocarcinoma cell lines by LANGDON, S. P, LAWRIE, S. S, HAY, F. G, HAWKES, M. M, MCDONALD, A, HAYWARD, I. P, SCHOL, D. J, HILGERS, J, LEONARD, R. C. F, SMYTH, J. F

“…Four series of cell lines have been derived from patients with ovarian adenocarcinoma. Nine cell lines have been established at one from a solid metastasis…”
Get full text

Nutrient Drinking Test as Biomarker in Functional Dyspepsia by Scarpellini, Emidio, Van den Houte, Karen, Schol, Jolien, Huang, I-Hsuan, Colomier, Ester, Carbone, Florencia, Tack, Jan

“…Functional dyspepsia (FD) is a prevalent condition with multifactorial pathophysiology, including impaired gastric accommodation (GA), hypersensitivity to…”
Get full text

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia by Wauters, Lucas, Dickman, Ram, Drug, Vasile, Mulak, Agata, Serra, Jordi, Enck, Paul, Tack, Jan, Accarino, Anna, Barbara, Giovanni, Bor, Serhat, Coffin, Benoit, Corsetti, Maura, De Schepper, Heiko, Dumitrascu, Dan, Farmer, Adam, Gourcerol, Guillaume, Hauser, Goran, Hausken, Trygve, Karamanolis, George, Keszthelyi, Daniel, Malagelada, Carolin, Milosavljevic, Tomislav, Muris, Jean, O’Morain, Colm, Papathanasopoulos, Athanassos, Pohl, Daniel, Rumyantseva, Diana, Sarnelli, Giovanni, Savarino, Edoardo, Schol, Jolien, Sheptulin, Arkady, Smet, Annemieke, Stengel, Andreas, Storonova, Olga, Storr, Martin, Törnblom, Hans, Vanuytsel, Tim, Velosa, Monica, Waluga, Marek, Zarate, Natalia, Zerbib, Frank

“…Background Functional dyspepsia (FD) is one of the most common conditions in clinical practice. In spite of its prevalence, FD is associated with major…”
Get full text

Activation of Tumor-Cell STING Primes NK-Cell Therapy by Knelson, Erik H, Ivanova, Elena V, Tarannum, Mubin, Campisi, Marco, Lizotte, Patrick H, Booker, Matthew A, Ozgenc, Ismail, Noureddine, Moataz, Meisenheimer, Brittany, Chen, Minyue, Piel, Brandon, Spicer, Nathaniel, Obua, Bonje, Messier, Cameron M, Shannon, Erin, Mahadevan, Navin R, Tani, Tetsuo, Schol, Pieter J, Lee-Hassett, Anna M, Zlota, Ari, Vo, Ha V, Ha, Minh, Bertram, Arrien A, Han, Saemi, Thai, Tran C, Gustafson, Corinne E, Venugopal, Kartika, Haggerty, Timothy J, Albertson, Thomas P, Hartley, Antja-Voy, Eser, Pinar O, Li, Ze-Hua, Cañadas, Israel, Vivero, Marina, De Rienzo, Assunta, Richards, William G, Abu-Yousif, Adnan O, Appleman, Vicky A, Gregory, Richard C, Parent, Alexander, Lineberry, Neil, Smith, Eric L, Jänne, Pasi A, Miret, Juan J, Tolstorukov, Michael Y, Romee, Rizwan, Paweletz, Cloud P, Bueno, Raphael, Barbie, David A

“…Activation of the stimulator of interferon genes (STING) pathway promotes antitumor immunity but STING agonists have yet to achieve clinical success. Increased…”
Get more information

Postinfectious onset in functional dyspepsia is a risk factor for weight loss by Schol, Jolien, Carbone, Florencia, Holvoet, Lieselot, Van den Houte, Karen, Colomier, Esther, Huang, I.-Hsuan, Scarpellini, Emidio, Vanuytsel, Tim, Tack, Jan

“…Background Functional dyspepsia (FD) is differentiated into two subgroups: the postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS). Acute…”
Get full text

Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis by Huang, I‐Hsuan, Schol, Jolien, Khatun, Rutaba, Carbone, Florencia, Van den Houte, Karen, Colomier, Esther, Balsiger, Lukas Michaja, Törnblom, Hans, Vanuytsel, Tim, Sundelin, Elias, Simrén, Magnus, Palsson, Olafur S., Bangdiwala, Shrikant I., Sperber, Ami D., Tack, Jan

“…Background/Objectives The global epidemiology of gastroparesis is unknown. The European UEG and European Society for Neurogastroenterology and motility…”
Get full text

Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001 by Langer, C J, Movsas, B, Hudes, R, Schol, J, Keenan, E, Kilpatrick, D, Yeung, C, Curran, W

“…The paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ)/carboplatin combination has demonstrated promising activity in patients with incurable…”
Get more information

A survey on the impact of the COVID‐19 pandemic on motility and functional investigations in Europe and considerations for recommencing activities in the early recovery phase by Tack, Jan, Schol, Jolien, Geeraerts, Annelies, Huang, I‐Hsuan, Mori, Hideki, Scarpellini, Emidio, Sinonquel, Pieter, Carbone, Florencia, Colomier, Esther, Geysen, Hannelore, Jandee, Sawangpong, Moonen, An, Pannemans, Jasper, Timmermans, Lien, Van den Houte, Karen, Verbeure, Wout, Wauters, Lucas, Bisschops, Raf, Hoffman, Ilse, Roelandt, Philip, Rommel, Nathalie, Simren, Magnus, Suzuki, Hidekazu, Tornblom, Hans, Verbeke, Kristin, Vanuytsel, Tim

“…Background The COVID‐19 pandemic, declared by WHO on March 13, 2020, had a major global impact on the healthcare system and services. In the acute phase, the…”
Get full text

'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence by Schol, D J, Meulenbroek, M F, Snijdewint, F G, von Mensdorff-Pouilly, S, Verstraeten, R A, Murakami, F, Kenemans, P, Hilgers, J

“…The ISOBM TD-4 Workshop antibodies 122-177 were tested for reactivity with 20 overlapping MUC1 tandem repeat 20-mer peptides by an ELISA, in order to determine…”
Get more information

Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines by LANGDON, S. P, HAWKES, M. M, HAY, F. G, LAWRIE, S. S, SCHOL, D. J, HILGERS, J, LEONARD, R. C. F, SMYTH, J. F

“…We have studied the effects of sodium butyrate, retinoic acid, and dimethyl sulfoxide on two human ovarian carcinoma cell lines PE04 and PE01. PE04 cells,…”
Get full text